Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?

Rezan Koçak Ulucaköy, Ayza Kılıç, Sevilay Batıbay, İdil Melis Çobanoğlu, Elif Nur Yıldırım Öztürk, Zafer Günendi, Aylin Sepici Dinçel, Feride Nur Göğüş

DOI: 10.46497/ArchRheumatol.2024.10360

Issue: Online First
0 380